SCHEMBL536369

SCHEMBL536369

CC(C)CC(CCCC(=O)O)(CC(C)C)C(=O)O

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 2/20 0.39
SLC22A6 Q4U2R8 2/20 0.39
AMPD2 Q01433 1/20 0.38
TSHR P16473 5/20 0.37
NFKB1 P19838 1/20 0.37
PMP22 Q01453 1/20 0.37
AKR1B1 P15121 1/20 0.37
GPR84 Q9NQS5 7/20 0.35
PPARG P37231 6/20 0.35
PPARD Q03181 6/20 0.35
PPARA Q07869 6/20 0.35
HDAC11 Q96DB2 5/20 0.35
ALDH1A1 P00352 2/20 0.35
TLR2 O60603 2/20 0.35
TDP1 Q9NUW8 2/20 0.35
FABP4 P15090 2/20 0.35
PTPN1 P18031 2/20 0.35
SLC22A8 Q8TCC7 1/20 0.35
MEN1 O00255 1/20 0.35
ESR1 P03372 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2230547 0.94 LMNA (0.42) LMNASLC22A6TSHRNFKB1PMP22
SCHEMBL4534219 0.92 TSHR (0.44) LMNASLC22A6TSHRNFKB1PMP22
SCHEMBL27998682 0.92 TSHR (0.44) LMNASLC22A6TSHRNFKB1PMP22
SCHEMBL8682820 0.92 TSHR (0.44) LMNASLC22A6TSHRNFKB1PMP22
SCHEMBL21114063 0.92 TSHR (0.44) LMNASLC22A6TSHRNFKB1PMP22
SCHEMBL1110756 0.90 AMPD2 (0.36) LMNASLC22A6AMPD2TSHRNFKB1
SCHEMBL18343639 0.90 AMPD2 (0.36) LMNASLC22A6AMPD2TSHRNFKB1
SCHEMBL536364 0.88 CYP1A2 (0.41) LMNASLC22A6AMPD2ALDH1A1MEN1
SCHEMBL4521730 0.85 TDP1 (0.33) LMNASLC22A6TSHRNFKB1PMP22
SCHEMBL11365667 0.85 ADRA1A (0.36) LMNASLC22A6TSHRNFKB1PMP22

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 643 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4739724-A1 MULTI-COMPONENT RESIN SYSTEM COMPRISING AT LEAST ONE PLASTICISER, MORTAR COMPOSITION BASED ON ISOCYANATE-AMINE ADDUCTS, AND METHOD AND USE OF THE MULTI-COMPONENT RESIN SYSTEM FOR FASTENING CONSTRUCTION ELEMENTS Hilti Aktiengesellschaft (LI) 2026-05-13 EP claimed
WO-2025011923-A1 MULTI-COMPONENT RESIN SYSTEM COMPRISING AT LEAST ONE PLASTICISER, MORTAR COMPOSITION BASED ON ISOCYANATE-AMINE ADDUCTS, AND METHOD AND USE OF THE MULTI-COMPONENT RESIN SYSTEM FOR FASTENING CONSTRUCTION ELEMENTS HILTI AKTIENGESELLSCHAFT (LI) 2025-01-16 WO claimed
EP-4488306-A1 MULTICOMPONENT RESIN SYSTEM WITH AT LEAST ONE PLASTICIZER, MORTAR BASED ON ISOCYANATE-AMINE ADDUCTS, AND METHOD AND USE OF THE MULTICOMPONENT RESIN SYSTEM FOR FASTENING CONSTRUCTION ELEMENTS Hilti Aktiengesellschaft (LI) 2025-01-08 EP claimed
EP-3449904-B1 EMULSIFIED COSMETIC SHINETSU CHEMICAL CO (JP) 2024-06-19 EP claimed
EP-3731021-B1 IMAGE FORMING METHOD AND IMAGE FORMING DEVICE, BROTHER IND LTD (JP) 2022-11-09 EP claimed
EP-3709962-B1 ANHYDROUS COMPOSITION COSMETICALLY ACCEPTABLE FOR USE AS NAIL POLISH INT LACQUERS (LU) 2022-01-26 EP claimed
EP-3211998-B1 PARASITICIDAL COMPOSITION COMPRISING FIPRONIL BOEHRINGER INGELHEIM ANIMAL HEALTH USA INC (US) 2021-04-07 EP claimed
EP-3421049-B1 LIQUID EXTERNAL PREPARATION HISAMITSU PHARMACEUTICAL CO (JP) 2020-07-29 EP claimed
EP-3125879-B1 PHEROMONE COMPOSITIONS INTENDED FOR TREATING STRESS-RELATED BEHAVIOURAL OR MEDICAL DISORDERS IN NON-HUMAN MAMMALS CEVA SANTE ANIMALE (FR) 2020-07-22 EP claimed
EP-3006547-B1 FRAGRANCE-CONTAINING CAPSULE AND COSMETIC IN WHICH SAID CAPSULES ARE BLENDED SHISEIDO CO LTD (JP) 2019-10-30 EP claimed
EP-1180359-A2 Cosmetic and dermatologic sunscreen compositions containing asymmetrically substituted triazine derivatives and dialkyladipates Beiersdorf AG (DE) 2002-02-20 EP claimed
US-20020015681-A1 Comprise a first and a second copolymer of polysiloxane and an vinyl monomer, having defined molecular weights, and present in a specific ratio to each other, impart a dichotomous viscosity behavior to the hair spray PROCTER & GAMBLE COMPANY, THE 2002-02-07 US claimed
WO-2002005766-A2 AEROSOL HAIR SPRAY COMPOSITIONS COMPRISING COMBINATIONS OF SILICONE-GRAFTED COPOLYMERS THE PROCTER & GAMBLE COMPANY (US) 2002-01-24 WO claimed
EP-1027889-A2 Ergolin derivates for transdermal application SCHERING AKTIENGESELLSCHAFT (DE) 2000-08-16 EP claimed
EP-0705094-B1 SKIN AND SCALP BARRIER FOR USE WITH HAIR TREATMENT PRODUCTS CARSON PROD CO (US) 2000-05-24 EP claimed
US-5795695-A PHOTO-QUALITY RECORDING XEROX CORPORATION (US) 1998-08-18 US claimed
EP-0537998-B1 Controlled release drug delivery device comprising a polymer matrix and a plasticizer MERCK & CO INC (US) 1997-01-15 EP claimed
EP-0046696-B1 ROTATING DISC EVAPO-EXTRUSION PROCESS AND APPARATUS THEREFOR SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 1986-06-04 EP claimed
EP-0084689-B1 PROCESS FOR THE MANUFACTURE OF A FOUNDRY CORE OR MOULD AKZO N.V. (NL) 1985-06-12 EP claimed
US-3965255-A DRUG ENCAPSULATED IN OR COATED WITH A SOLVENT MEMBRANE E. E. ELJIM ECOLOGY LTD. (IL) 1976-06-22 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020015681-A1 Comprise a first and a second copolymer of polysiloxane and an vinyl monomer, having defined molecular weights, and present in a specific ratio to each other, impart a dichotomous viscosity behavior to the hair spray CD44, SHH, SHBG LMNA 2300/4885SLC22A6 3866/4885AMPD2 4725/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.